Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

UCLA researcher looks for ways to detect ovarian cancer before it develops

Out of the 22,240 women in the United States who are diagnosed with ovarian cancer every year, only about 47 percent survive longer than five years.

28 Jun 2019

Heat from nanoparticles zaps cancer cells from inside

Oregon State University researchers have come up with nanoclusters that are capable of reaching within tumours that are difficult to reach. The results of this breakthrough in cancer therapeutics were published in a study in the latest issue of the journal ACS Nano.

26 Jun 2019

New blood test offers more precise diagnostics of ovarian cancer

The majority of women who undergo surgery for suspected ovarian cancer do not have cancer. A novel blood test developed by researchers at Uppsala University and the Sahlgrenska Academy, University of Gothenburg, in Sweden, now offers the possibility of more precise diagnostics without the need for surgery.

20 Jun 2019

Study reveals potential consequences of limiting ovarian cancer surgery to high-volume hospitals

Limiting ovarian cancer surgery to high-volume hospitals could improve survival but may also reduce access for many rural and underserved patients, a new study from researchers at Columbia University Vagelos College of Physicians and Surgeons has found.

20 Jun 2019

Use of molecular biomarkers shows promise in early detection of endometrial cancer

The use of molecular biomarkers in minimally invasive sampling opens a promising perspective for the early detection of endometrial cancer.

18 Jun 2019

First clinical test could enable personalized prognosis for triple-negative breast cancer patients

A personalized prognosis for patients diagnosed with triple-negative breast cancer was the goal of a new study by Katherine Varley, PhD, researcher at Huntsman Cancer Institute and assistant professor of oncological sciences at the University of Utah.

13 Jun 2019

A 'one-two punch' approach to destroy cancerous ovarian cells

Researchers from the University of Montreal Hospital Research Centre have developed a two-step combination therapy to destroy cancer cells.

11 Jun 2019

Complex molecular conversation is key to the establishment of 'hot tumor'

A Ludwig Cancer Research study has deciphered a complex molecular conversation between cancer and immune cells that is key to orchestrating the successful invasion of tumors by T cells that kill cancer cells.

11 Jun 2019

Research sheds new light on the function of frequently mutated cancer protein

New research from The Wistar Institute sheds light on the function of the ARID1A protein, encoded by a gene that is among the most frequently mutated across human cancers.

24 May 2019

CRISPR uncovers which gene fusions are critical for growth of cancer cells

In the first large-scale analysis of cancer gene fusions, which result from the merging of two previously separate genes, researchers at the Wellcome Sanger Institute, EMBL-EBI, Open Targets, GSK and their collaborators have used CRISPR to uncover which gene fusions are critical for the growth of cancer cells.

16 May 2019

‘Living their values’: Palliative care power couple faces cancer at home

In the 18 years that Kathy Brandt and Kim Acquaviva have been together, death has been a constant companion.

15 May 2019

NIH announces awards to advance development of vaccines for sexually transmitted infections

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today announced awards to establish four Cooperative Research Centers focused on developing vaccines to prevent sexually transmitted infections.

10 May 2019

UNC and partners receive NIH funding to identify chlamydia vaccine

Chlamydia is the most prevalent bacterial sexually transmitted infection (STI) in the world. There is no vaccine to prevent infection. However, researchers from the University of North Carolina at Chapel Hill, in partnership with colleagues at other sites in the US, Europe and Australia, will receive up to $10.7 million over five years from the National Institutes of Health (NIH) to move closer to identifying a vaccine candidate.

10 May 2019

Study could lead to improved diagnosis and treatment of ovarian cancer

Oncologists may soon have an accurate and inexpensive way of differentiating between types of ovarian cancer that will improve how patients are treated, thanks to findings from a national research study co-led out of the University of Alberta.

8 May 2019

Unexpected role of junk RNA in cancer opens new way for treatment of the disease

In an article just published by Trends in Cancer online, Dr. Alan Herbert, founder at InsideOutBio, highlights how the way cancer cells solve the problem of junk RNA makes them vulnerable to a new type of cancer therapy.

7 May 2019

Circulating tumor DNA can help detect treatment options for ovarian cancer subtype

According to a new research, circulating tumor DNA can be used detect treatment options for ovarian cancer patients who don't benefit from chemotherapy.

6 May 2019

Researchers identify 34 genes associated with increased risk of ovarian cancer

A team of researchers at UCLA's Jonsson Comprehensive Cancer, Cedars-Sinai Cancer and Dana-Farber Cancer Institute have newly identified 34 genes that are associated with an increased risk for developing the earliest stages of ovarian cancer.

1 May 2019

Delving into tumor's cellular lineage may offer clues for customized therapies

To explain a person's actions in the present, it sometimes helps to understand their past, including where they come from and how they were raised.

25 Apr 2019

Johns Hopkins researchers uncover role of neurotransmitter in the spread of aggressive cancers

Using human cancer cells, tumor and blood samples from cancer patients, researchers at Johns Hopkins Medicine have uncovered the role of a neurotransmitter in the spread of aggressive cancers. Neurotransmitters are chemical "messengers" that transmit impulses from neurons to other target cells.

25 Apr 2019